• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义泰国全民覆盖计划的福利包:从实用主义到复杂化。

Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.

机构信息

International Health Policy Program, Ministry of Public Health, Nonthaburi, Thailand.

National Health Security Office, Bangkok, Thailand.

出版信息

Int J Health Policy Manag. 2020 Apr 1;9(4):133-137. doi: 10.15171/ijhpm.2019.96.

DOI:10.15171/ijhpm.2019.96
PMID:32331492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7182149/
Abstract

Benefit package is crucial for implementing universal health coverage (UHC). This editorial analyses how the benefit package of the Thai Universal Coverage Scheme (UC Scheme) evolved from an implicit comprehensive package which covered all conditions and interventions (with a few exceptions), to additional explicit positive lists. In 2002 when the Thai UC Scheme was launched; the comprehensive benefit package, including medicines in the national essential list of medicines, formerly offered by the previous schemes were pragmatically adopted. Later, when capacities of producing evidence on health technology assessment (HTA) increased, rigorous assessment of cost effectiveness is mandatorily required for inclusion of new interventions into the Thai UC Scheme benefit package. This contributed to evidence-informed policy decisions. To prevent emptied promises, whichever policy choices are made about the benefit package, either using a negative or a positive list, developing country governments need to make quality health services available and accessible by the entire population. Political decision on benefit package should be informed by evidence on cost effectiveness, equity dimension and health system capacity to deliver equitable services. Low- and middle-income countries need to strengthen HTA capacity to generate evidence and inform policies.

摘要

福利套餐对于实施全民健康覆盖(UHC)至关重要。本社论分析了泰国全民覆盖计划(UC 计划)的福利套餐如何从涵盖所有条件和干预措施(少数例外)的隐含综合套餐演变为额外的明确正面清单。2002 年,泰国 UC 计划启动时,以前各计划提供的国家基本药物清单中的药品等实用综合福利套餐被采用。后来,随着对卫生技术评估(HTA)证据生产能力的提高,必须对新干预措施纳入泰国 UC 计划福利套餐进行严格的成本效益评估。这有助于为政策决策提供循证依据。为了防止空口承诺,无论使用负面清单还是正面清单,制定有关福利套餐的政策选择,发展中国家政府都需要通过全民提供和获得优质的卫生服务。关于福利套餐的政治决策应参考成本效益、公平维度和卫生系统提供公平服务的能力方面的证据。中低收入国家需要加强 HTA 能力,以生成证据并为政策提供信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b438/7182149/2dd06424c7c9/ijhpm-9-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b438/7182149/2dd06424c7c9/ijhpm-9-133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b438/7182149/2dd06424c7c9/ijhpm-9-133-g001.jpg

相似文献

1
Defining the Benefit Package of Thailand Universal Coverage Scheme: From Pragmatism to Sophistication.定义泰国全民覆盖计划的福利包:从实用主义到复杂化。
Int J Health Policy Manag. 2020 Apr 1;9(4):133-137. doi: 10.15171/ijhpm.2019.96.
2
Policy Choices for Progressive Realization of Universal Health Coverage Comment on "Ethical Perspective: Five Unacceptable Trade-offs on the Path to Universal Health Coverage".逐步实现全民健康覆盖的政策选择——评“伦理视角:通往全民健康覆盖道路上的五个不可接受的权衡”
Int J Health Policy Manag. 2017 Feb 1;6(2):107-110. doi: 10.15171/ijhpm.2016.99.
3
Universal Health Coverage and Essential Packages of Care全民健康覆盖与基本医疗服务包
4
Universal access to comprehensive COVID-19 services for everyone in Thailand.在泰国为每个人提供全面的 COVID-19 服务的普及。
BMJ Glob Health. 2022 Jun;7(6). doi: 10.1136/bmjgh-2022-009281.
5
Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity.推动普遍金融保护:泰国全民覆盖计划如何确保公平性。
Health Res Policy Syst. 2013 Aug 6;11:25. doi: 10.1186/1478-4505-11-25.
6
Health Technology Assessment in Thailand: Institutionalization and Contribution to Healthcare Decision Making: Review of Literature.泰国的卫生技术评估:制度化与对医疗保健决策的贡献:文献回顾。
Int J Technol Assess Health Care. 2019;35(6):467-473. doi: 10.1017/S0266462319000321. Epub 2019 Jun 13.
7
Revisiting Roles of Health Technology Assessment on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?重新审视卫生技术评估在泰国全民健康覆盖药物政策中的作用:我们目前处于什么阶段?下一步是什么?
Value Health Reg Issues. 2019 May;18:78-82. doi: 10.1016/j.vhri.2018.11.004. Epub 2019 Jan 12.
8
Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment.全民健康覆盖下健康筛查套餐的制定:卫生技术评估的作用
Health Econ. 2016 Feb;25 Suppl 1(Suppl Suppl 1):162-78. doi: 10.1002/hec.3301. Epub 2016 Jan 15.
9
Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand.程序公平性在福利套餐设计中的应用:泰国全民医疗保险计划纳入艾滋病毒暴露前预防。
Health Policy Plan. 2023 Nov 14;38(Supplement_1):i36-i48. doi: 10.1093/heapol/czad061.
10
Participatory and responsive governance in universal health coverage: an analysis of legislative provisions in Thailand.全民健康覆盖中的参与式和回应式治理:对泰国立法条款的分析。
BMJ Glob Health. 2021 Feb;6(2). doi: 10.1136/bmjgh-2020-004117.

引用本文的文献

1
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?评估1型和3b型戈谢病中酶替代疗法的性价比:扩大覆盖范围是否合理?
Pharmacoecon Open. 2025 Apr 29. doi: 10.1007/s41669-025-00579-x.
2
Characterization of treatment intensified (add-on to metformin) adults with type 2 diabetes in Thailand: A cross-sectional real-world study (CONVERGE).泰国强化治疗(二甲双胍基础上加用其他药物)的2型糖尿病成人患者特征:一项横断面真实世界研究(CONVERGE)
J Diabetes Investig. 2025 Jun;16(6):1010-1019. doi: 10.1111/jdi.14409. Epub 2025 Mar 12.
3
Early health technology assessment of tongue swab for non-sputum based pulmonary tuberculosis diagnosis in Thailand.

本文引用的文献

1
Defining a Health Benefits Package: What Are the Necessary Processes?定义健康福利套餐:必要流程有哪些?
Health Syst Reform. 2016 Jan 2;2(1):39-50. doi: 10.1080/23288604.2016.1124171.
2
Accounting for Technical, Ethical, and Political Factors in Priority Setting.在确定优先事项时考虑技术、伦理和政治因素。
Health Syst Reform. 2016 Jan 2;2(1):51-60. doi: 10.1080/23288604.2016.1124169.
3
Improving access to antidotes and antivenoms, Thailand.改善抗毒血清和抗蛇毒血清的可及性,泰国。
泰国基于非痰液样本的肺结核诊断中舌拭子的早期卫生技术评估
Lancet Reg Health Southeast Asia. 2025 Jan 28;33:100533. doi: 10.1016/j.lansea.2025.100533. eCollection 2025 Feb.
4
Value is Gendered: The Need for Sex and Gender Considerations in Health Economic Evaluations.价值存在性别差异:卫生经济评估中考虑性与性别的必要性。
Appl Health Econ Health Policy. 2025 Mar;23(2):171-181. doi: 10.1007/s40258-024-00930-z. Epub 2024 Dec 12.
5
Challenges in institutionalizing evidence-informed priority setting for health service packages: a qualitative document and interview analysis from Iran.将证据转化为健康服务套餐优先事项的制度化挑战:来自伊朗的定性文件和访谈分析。
Health Res Policy Syst. 2024 Aug 19;22(1):110. doi: 10.1186/s12961-024-01207-6.
6
Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries.弥合现实世界的数据差距:连接10个亚洲国家的数据点。
JMIR Med Inform. 2024 Aug 15;12:e58548. doi: 10.2196/58548.
7
Understanding the extent of economic evidence usage for informing policy decisions in the context of India's national health insurance scheme: Ayushman Bharat Pradhan Mantri Jan Aarogya Yojana (PM-JAY).了解印度国家医疗保险计划(阿育王 Bharat Pradhan Mantri Jan Aarogya Yojana,简称 PM-JAY)背景下,用于为政策决策提供信息的经济证据使用程度。
BMJ Glob Health. 2024 Jun 10;9(6):e015079. doi: 10.1136/bmjgh-2024-015079.
8
A situational and stakeholder analysis of health technology assessment in Zimbabwe.津巴布韦卫生技术评估的情境和利益相关者分析。
Int J Technol Assess Health Care. 2024 Apr 29;40(1):e27. doi: 10.1017/S0266462324000266.
9
Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand.程序公平性在福利套餐设计中的应用:泰国全民医疗保险计划纳入艾滋病毒暴露前预防。
Health Policy Plan. 2023 Nov 14;38(Supplement_1):i36-i48. doi: 10.1093/heapol/czad061.
10
Procedural fairness in health financing for universal health coverage: why, what and how.全民健康覆盖卫生筹资中的程序公平:为何、是什么以及如何实现。
Health Policy Plan. 2023 Nov 14;38(Supplement_1):i1-i4. doi: 10.1093/heapol/czad069.
Bull World Health Organ. 2018 Dec 1;96(12):853-857. doi: 10.2471/BLT.18.217075. Epub 2018 Oct 29.
4
Scoping literature review on the basic health benefit package and its determinant criteria.基本卫生福利包及其决定标准的范围文献综述。
Global Health. 2018 Mar 2;14(1):26. doi: 10.1186/s12992-018-0345-x.
5
Health systems development in Thailand: a solid platform for successful implementation of universal health coverage.泰国的卫生系统发展:成功实施全民健康覆盖的坚实平台。
Lancet. 2018 Mar 24;391(10126):1205-1223. doi: 10.1016/S0140-6736(18)30198-3. Epub 2018 Feb 1.
6
PD First Policy: Thailand's Response to the Challenge of Meeting the Needs of Patients With End-Stage Renal Disease.PD 优先政策:泰国应对满足终末期肾病患者需求的挑战。
Semin Nephrol. 2017 May;37(3):287-295. doi: 10.1016/j.semnephrol.2017.02.008.
7
Expanding access to high-cost medicines through the E2 access program in Thailand: effects on utilisation, health outcomes and cost using an interrupted time-series analysis.通过泰国的E2获取计划扩大高成本药品的可及性:采用中断时间序列分析对药品使用、健康结果及成本的影响
BMJ Open. 2016 Mar 17;6(3):e008671. doi: 10.1136/bmjopen-2015-008671.
8
Guidelines for health technology assessment in Thailand (second edition)--the development process.泰国卫生技术评估指南(第二版)——制定过程
J Med Assoc Thai. 2014 May;97 Suppl 5:S4-9.
9
Promoting universal financial protection: how the Thai universal coverage scheme was designed to ensure equity.推动普遍金融保护:泰国全民覆盖计划如何确保公平性。
Health Res Policy Syst. 2013 Aug 6;11:25. doi: 10.1186/1478-4505-11-25.
10
Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand.多准则决策分析在泰国全民健康覆盖福利包中纳入健康干预措施。
Value Health. 2012 Sep-Oct;15(6):961-70. doi: 10.1016/j.jval.2012.06.006.